Related Experiment Video
Updated: Jun 17, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Wnt/beta-catenin modulation: A promising frontier in chronic kidney disease management
Shubhangi Saxena1, Neha Dagar1, Vishwadeep Shelke1
1Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Pilani Campus, Pilani, Rajasthan, India.
Background:
Being amongst the leading factors of death and distress, chronic kidney disease (CKD) has affected around 850 million people globally. The Wnt/β-catenin axis is vital for maintaining kidney homeostasis, from nephron generation to overall management. The β-catenin growth factor is typically not expressed in the adult kidney; however, its expression is found to increase under stress and injury conditions. It is categorised as canonical and non-canonical based on β-catenin availability, which mounts promising targets for ameliorating CKD. Hence, modulation of the Wnt/β-catenin signalling for CKD management is of utmost relevance.
Objectives:
The primary aim of this review is to highlight the significance of targeting Wnt/β-catenin signalling for CKD management.
Methods:
The literature review regarding the role of Wnt/β-catenin signalling and therapies modulating it in CKD was conducted using PubMed, Scopus, Science Direct and Google Scholar.
Results:
The current review summarises the pharmacological therapies modulating the Wnt/β-catenin axis in CKD, building upon promising preclinical studies to establish a foundation for clinical studies in the future.
Conclusion:
Wnt/β-catenin signalling is the evolution's most conserved pathway, which plays a pivotal role in CKD progression. Therapies modulating Wnt/β-catenin signalling have emerged as effective means for alleviating CKD.
Insights
Targeting the Wnt/β-catenin pathway shows promise for managing chronic kidney disease (CKD). Modulating this conserved signaling pathway offers effective therapeutic strategies for alleviating CKD progression.
Area of Science:
- Nephrology
- Molecular Biology
- Pharmacology
Background:
- Chronic kidney disease (CKD) affects 850 million globally, posing significant health challenges.
- The Wnt/β-catenin signaling pathway is crucial for kidney homeostasis and is dysregulated in CKD.
- β-catenin expression increases in adult kidneys under stress, making it a potential therapeutic target.
Purpose of the Study:
- To review the significance of targeting the Wnt/β-catenin signaling pathway for CKD management.
- To highlight the role of Wnt/β-catenin modulation in alleviating CKD.
Main Methods:
- Comprehensive literature review using PubMed, Scopus, Science Direct, and Google Scholar.
- Focused on studies investigating Wnt/β-catenin signaling in CKD and related therapeutic interventions.
Main Results:
- Summarizes pharmacological therapies that modulate the Wnt/β-catenin axis in CKD.
- Highlights promising preclinical findings that support future clinical investigations.
Conclusions:
- Wnt/β-catenin signaling is a highly conserved pathway critical to CKD progression.
- Therapies targeting Wnt/β-catenin signaling represent effective strategies for CKD treatment.
More Related Videos
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Related Concept Videos
Canonical Wnt Signaling Pathway
Nephrons
Non-Canonical Wnt Signaling Pathways
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System